User profiles for Farinaz Safavi
 | Farinaz Safavi MD, Ph.DNational Institutes of Health (NIH) Verified email at nih.gov Cited by 2385 |
Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection
Postinfection complications of coronavirus disease 2019 (COVID-19) are still unknown, and
one of the long-term concerns in infected people are brain pathologies. The question is that …
one of the long-term concerns in infected people are brain pathologies. The question is that …
Role of serine proteases in inflammation: Bowman–Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases
Serine proteases, a sub-category of the protease family, participate in various physiologic
and pathologic conditions. Serine proteases are involved in different arms of the immune …
and pathologic conditions. Serine proteases are involved in different arms of the immune …
The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
Interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) require exposure to IL-23 to
become encephalitogenic, but the mechanism by which IL-23 promotes their pathogenicity is …
become encephalitogenic, but the mechanism by which IL-23 promotes their pathogenicity is …
Neurovascular injury with complement activation and inflammation in COVID-19
…, J Steiner, N Pasternack, W Li, D Maric, F Safavi… - Brain, 2022 - academic.oup.com
The underlying mechanisms by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
leads to acute and long-term neurological manifestations remains obscure. We …
leads to acute and long-term neurological manifestations remains obscure. We …
Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection
Heparan sulfate proteoglycans (HSPGs) are cell surface receptors that are involved in the
cellular uptake of pathologic amyloid proteins and viruses, including the novel coronavirus; …
cellular uptake of pathologic amyloid proteins and viruses, including the novel coronavirus; …
Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-β therapy
Multiple sclerosis (MS) is an autoimmune disease of the CNS. Studies in animal models of
MS have shown that GM-CSF produced by T cells is necessary for the development of …
MS have shown that GM-CSF produced by T cells is necessary for the development of …
Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods
One of the most critical challenges in managing complex diseases like COVID-19 is to establish
an intelligent triage system that can optimize the clinical decision-making at the time of a …
an intelligent triage system that can optimize the clinical decision-making at the time of a …
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
Objective To determine whether the course of COVID-19 is more severe in patients with MS
and if MS disease-modifying treatments (DMTs) affect the risk of contracting the disease. …
and if MS disease-modifying treatments (DMTs) affect the risk of contracting the disease. …
[HTML][HTML] Neuropathic symptoms with SARS-CoV-2 vaccination
F Safavi, L Gustafson, B Walitt, T Lehky, S Dehbashi… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Results: In an observational study, we studied 23 patients (92% female; median age
40years) reporting new neuropathic symptoms beginning within 1 month after SARS-CoV-2 …
40years) reporting new neuropathic symptoms beginning within 1 month after SARS-CoV-2 …
Functional neurological disorder after SARS-CoV-2 vaccines: two case reports and discussion of potential public health implications
The scientific community responded rapidly to the COVID-19 pandemic by developing novel
SARS-CoV-2 vaccines that have been shown to be safe and effective (1). Global …
SARS-CoV-2 vaccines that have been shown to be safe and effective (1). Global …
